Breastfeeding and drug management in connective tissue and rheumatic diseases;Traitements de fond des affections inflammatoires systémiques au cours de l'allaitement

Revue de Medecine Interne

Volumn 29, Issue 12, 2008, Pages 1017-1023

  Weber, J C ^a   Kuhnert, C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Benefit risk assessment; Breastfeeding; Connective tissue diseases; Immunosuppressive agents

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLOROQUINE; COLCHICINE; COLCHIMAX; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TACROLIMUS; TIOGUANINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BREAST FEEDING; CONNECTIVE TISSUE DISEASE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EXCRETION; DRUG INDUSTRY; DRUG INFORMATION; DRUG MILK LEVEL; DRUG SAFETY; DRUG TRANSPORT; DRUG USE; HUMAN; LACTATION; MATERNAL DISEASE; MEDICAL EXPERT; RHEUMATIC DISEASE; RISK BENEFIT ANALYSIS; SHORT SURVEY;

ADULT; ANTIRHEUMATIC AGENTS; BREAST FEEDING; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; LACTATION; RHEUMATIC DISEASES; RISK ASSESSMENT;

EID: 56249144783     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.05.022     Document Type: Short Survey

References (58)

1. Organisation mondiale de la santé. Stratégie mondiale pour l'alimentation du nourrisson et du jeune enfant; 2003. Texte disponible à : http://www.who.int/nutrition/publications/gs_infant_feeding_text_fre.pdf (Consulté le 27/06/08).
2. Allen J., and Hector D. Benefits of breastfeeding. N S W Public Health Bull 16 (2005) 42-46
3. Ong K.K., and Forouhi N. Communicating the benefits of breast feeding. Arch Dis Child 92 (2007) 471-472
4. Agence nationale d'accréditation et d'évaluation en santé. Allaitement maternel : mise en œuvre et poursuite dans les six premiers mois de vie de l'enfant. Recommandations (mai 2002). Gynecol Obstet Fertil 2003;31:481-90.
5. Worlds Health Organization. The optimal duration of exclusive breastfeeding. A systematic review; 2002. Texte disponible à : http://www.who.int/nutrition/publications/optimal_duration_of_exc_bfeeding_review_eng.pdf (Consulté le 27/06/08).
6. Scanlon K.S., Grummer-Strawn L., Shealy K.R., Jefferds M.E., Chen J., Singleton J.A., et al. Breastfeeding trends and updated national health objectives for exclusive breastfeeding - United States, birth years 2000-2004. MMWR Morb Mortal Wkly Rep 56 (2007) 760-763
7. Moore M.L. Current research continues to support breastfeeding benefits. J Perinat Educ 10 (2001) 38-40
8. Coulibaly R., Séguin L., Zunzunegui M.V., and Gauvin L. Links between maternal breast-feeding duration and Québec infants' health: a population-based study. Are the effects different for poor children?. Matern Child Health J 10 (2006) 537-543
9. Ito S., and Lee A. Drug excretion into breast milk - overview. Adv Drug Deliv Rev 55 (2003) 617-627
10. Lewallen L.P., Dick M.J., Flowers J., Powell W., Zickefoose K.T., Wall Y.G., et al. Breastfeeding support and early cessation. J Obstet Gynecol Neonatal Nurs 35 (2006) 166-172
11. Ito S., Koren G., and Einarson T.R. Maternal noncompliance with antibiotics during breastfeeding. Ann Pharmacother 27 (1993) 40-42
12. Ito S., Moretti M., Liau M., and Koren G. Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Obstet Gynecol 172 (1995) 881-886
13. Lee A., Moretti M., Collantes A., Chong D., Mazzotta P., Koren G., et al. Choice of breastfeeding and physicians' advice: a cohort study of women receiving propylthiouracil. Pediatrics 106 (2000) 27-30
14. Stowe Z.N. The use of mood stabilizers during breastfeeding. J Clin Psych 68 suppl. 9 (2007) 22-28
15. Feig D.S., Briggs G.G., and Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?. Ann Pharmacother 41 (2007) 1174-1180
16. Gremmo-Féger G., Dobrzynski M., and Collet M. Allaitement maternel et médicaments. J Gynecol Obstet Biol Reprod 32 (2003) 466-475
17. Ostensen M., and Motta M. Therapy insight: the use of antirheumatic drugs during nursing. Nat Clin Pract Rheumatol 3 (2007) 400-406
18. Vukusic S., and Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 108 (2006) 266-270
19. Chapelon Abric C., Ginsburg C., Biousse V., Wechsler B., de Gennes C., Darbois Y., et al. Sarcoïdose et grossesse ; étude rétrospective de 11 cas. Rev Med Interne 19 (1998) 305-312
20. Renaud C., de Montgolfier I., Vautier-Brouzes D., Costedoat-Chalumeau N., Lapillonne A., and Gold F. Conséquences périnatales des connectivites maternelles : étude prospective de 73 cas. Arch Pediatr 13 (2006) 1386-1390
21. Tincani A., Biasini Rebaioli T.C., Frassi M., Taglietti M., Gorla R., Cavazzana I., et al. Pregnancy and autoimmunity: Maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev 4 (2005) 423-428
22. Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002;17(suppl. 4):50-5.
23. Sau A., Clarke S., Bass J., Kaiser A., Marinaki A., and Nelson-Piercy C. Azathioprine and breasfeeding - is it safe?. Br J Obstet Gynecol 114 (2007) 498-501
24. Ferrero S., and Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet 270 (2004) 79-85
25. Ferrero S., Pretta S., and Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 115 (2004) 3-9
26. Kane S., and Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 100 (2005) 102-105
27. Ostensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209-227
28. Pourrat O. La médecine obstétricale : une mission de choix pour l'interniste. Rev Med Interne 25 (2004) 419-420
29. Heetun Z.S., Byrnes C., Neary P., and O'Morain C. Reproduction in the patient with inflammatory bowel disease. Alim Pharmacol Ther 26 (2007) 513-533
30. Werner M., Björnsson E., Prytz H., Lindgren S., Almer S., Broomé U., et al. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?. Scand J Gastroenterol 42 (2007) 986-991
31. Lactmed: Drugs and Lactation Database of the National Library of Medicine, United States. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT (Consulté le 27/06/08).
32. Centre de référence sur les agents tératogènes. http://www.lecrat.org (Consulté le 27/06/08).
33. Texas Tech University, Breastfeeding Pharmacology, Breastfeeding and medications forums. http://neonatal.ttuhsc.edu/lact (Consulté le 27/06/08).
34. e édition est annoncée pour juillet 2008)
35. Ito S. Drug therapy for breasfeeding women. N Engl J Med 343 (2000) 118-126
36. Ito S., and Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 38 (1994) 99-102
37. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 108 (2001) 776-779
38. Ost L., Wettrell G., Björkhem I., and Rane A. Prednisolone excretion in human milk. J Pediatr 106 (1985) 1008-1011
39. Behar-Cohen F.F., Gauthier S., Elaouni A., Chapon P., Parel J.M., Renard G., et al. Methylprednisolone concentrations in the vitreous and the serum after pulse therapy. Retina 21 (2001) 48-53
40. Siminoski K., Fitzgerald A.A., Flesch G., and Gross M.S. Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding. J Bone Miner Res 15 (2000) 2052-2055
41. Costedoat-Chalumeau N., Amoura Z., Aymard G., Le Thi Huong D., Wechsler B., Vauthier D., et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 46 (2002) 1123-1124
42. Motta M., Tincani A., Faden D., Zinzini E., Lojacono A., Marchesi A., et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25 (2005) 86-89
43. Costedoat-Chalumeau N., Amoura Z., Le Thi Huong D., Wechsler B., and Piette J.C. Plaidoyer pour le maintien de l'hydroxychloroquine dans les grossesses lupiques. Rev Med Interne 26 (2005) 467-469
44. Costedoat-Chalumeau N., Amoura Z., Le Thi Huong D., Lechat P., and Piette J.C. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4 (2005) 111-115
45. Temprano K.K., Bandlamudi R., and Moore T.L. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35 (2005) 112-121
46. Moretti M.E., Lee A., and Ito S. Which drugs are contraindicated during breastfeeding?. Can Fam Physician 46 (2000) 1753-1757
47. Edstein M.D., Veenendaal J.R., Newman K., and Hyslop R. Excretion of chloroquin, dapsone and pyrimethamine in human milk. Br J Clin Pharmacol 22 (1986) 733-735
48. Sanders S.W., Zone J.J., Foltz R.L., Tolman K.G., and Rollins D.E. Hemolytic anemia induced by dapsone transmitted through breast milk. Ann Intern Med 96 (1982) 465-466
49. Brabin B.J., Eggelte T.A., Parise M., and Verhoeff F. Dapsone therapy for malaria during pregnancy. Maternal and fetal outcomes. Drug Saf 27 (2004) 633-648
50. Guillonneau M., Jacqz Aigrain E., Galliot M., Binet M.H., and Darbois Y. Colchicine is excreted at high concentrations in human breast milk. Eur J Obstet Gynecol Reprod Biol 61 (1995) 177-178
51. Ben-Chetrit E., Scherrmann J.M., and Levy M. Colchicine in breast milk of patients with familial mediterranean fever. Arthritis Rheum 39 (1996) 1213-1217
52. Grimer M. Pregnancy, lactation and calcineurin inhibitors. Nephrology 12 suppl. 1 (2007) S98-S105
53. Nyberg G., Haljamäe U., Frisenette-Fich C., Wennergren M., and Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 65 (1998) 253-255
54. Moretti M.E., Sgro M., Johnson D.W., Sauve R.S., Woolgar M.J., Taddio A., et al. Cyclosporine excretion into breast milk. Transplantation 75 (2003) 2144-2146
55. Gardiner S.J., and Begg E.J. Breastfeeding during tacrolimus therapy. Obstet Gynecol 107 (2006) 453-455
56. Moretti M.E., Verjee Z., Ito S., and Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 40 (2006) 2269-2272
57. Gardiner S.J., Gearry R.B., Roberts R.L., Zhang M., Barclay M.L., and Begg E.J. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 62 (2006) 453-456
58. Ostensen M., and Eigenmann G.O. Etanercept in breast milk. J Rheumatol 31 (2004) 1017